CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD
- Conditions
- Chronic Kidney DiseaseDiabetes
- Registration Number
- NCT07210710
- Lead Sponsor
- University of Illinois at Chicago
- Brief Summary
The goal of this pilot clinical trial is to learn if an intervention delivering education, motivational support, and social support can prevent worsening kidney disease in adults with diabetes and early-stage kidney disease. The main questions it aims to answer are:
1. Is this intervention feasible to deliver and acceptable to patients?
2. What is the impact of the intervention on patient motivation, self-efficacy, kidney disease knowledge, and use of support services referrals?
The investigators will compare information collected about participants' response to this intervention with a group of similar patients who receive general diabetes information.
Participants will meet virtually with a nurse approximately 1 week before a scheduled primary care provider visit and complete surveys over the phone three times in a period of three months.
- Detailed Description
Chronic kidney disease (CKD) progression to kidney failure causes devastating declines in quality of life and mortality, with high healthcare costs. CKD affects \~15% of all adults in the U.S. and \~40% of adults with diabetes, with substantial variability in rate of progression to kidney failure. Negative social determinants of health (SDOH), such as food insecurity can speed up disease progression. However, if CKD progression to kidney failure can be prevented or delayed, patients can experience minimal impact on health and well-being. The diagnosis, treatment, and monitoring of early-stage, asymptomatic CKD occurs predominantly in the primary care setting, including for those with diabetes. Unfortunately, the rates of guideline-based CKD care delivery are low, and as a result, clinical diagnosis of early-stage CKD is as low as 50%. Delay in receiving a CKD diagnosis is associated with faster progression to kidney failure. Furthermore, because CKD is not always prioritized in the busy primary care setting, most patients are unaware they have CKD and have low rates of CKD knowledge, which impedes their ability to adhere to treatment. To address the issues of underdiagnosis, patients' lack of disease knowledge and self-efficacy, and the impact of SDOH for patients with diabetes and CKD, proactive action is critical. The investigators will target patients with diabetes who are eligible for an early-stage CKD diagnosis with a nurse-led, pre-primary care-visit 1:1 virtual session including evidence-based CKD education, motivational interviewing, and SDOH screening with referrals to services.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 50
- adults (18+)
- diabetes diagnosis (type 1 or 2)
- CKD Stage 3 diagnosis eligible
- >1 prior visit at the UIHealth primary care clinics
- can speak English
- CKD of congenital or pediatric onset
- history of kidney transplant
- cognitive impairment as documented in the medical record
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Motivation for diabetes-related self-care behaviour scale From enrollment to study completion (2-3 months) Participant self-report. A scale from 1-5, with a lower score meaning not motivated and a higher score meaning highly motivated. Items are different self-management behaviors (e.g., medication, diet, exercise).
Kidney Disease Knowledge Survey From enrollment to study completion (2-3 months) Participant self-report. A set of fact-based questions about kidney disease which has a right and a wrong answer. Participants will be scored based on % correct answers.
CKD Self Efficacy Instrument From enrollment to study completion (2-3 months) Participant self-report. The scale ranges from 1-10, with low scores indicating not at all confident and high scores indicating totally confident.
Social referral uptake From enrollment to study completion (2-3 months) Participant self-report of uptake of any support services for barriers to treatment adherence that are needed.
- Secondary Outcome Measures
Name Time Method Brief Illness Perceptions Questionnaire From enrollment to study completion (2-3 months) Participant self-report. Scale from 1-10, with the meaning of numbers changing per item. Assessing participants' perspective and understanding of their chronic condition. Items assessed individually or using clustering approaches.
Patient activation Measure From enrollment to study completion (2-3 months) Participant self-report. Scales are 1-4 with a not applicable option, lower scores meaning less activated and engaged in care and higher scores meaning more activated and engaged in care.
PROMIS Medication Adherence Scale From enrollment to study completion (2-3 months) Participant self-report. Scale from 1-5 indicating agree to disagree, with items about performance of medication adherence behaviors.
Dialysis Diet and Fluid Non-adherence Questionnaire From enrollment to study completion (2-3 months) Participant self-report. One item asking how many days in the last week guidelines were not followed, and another item asking to what degree they were not followed, from completely to not at all.
International Physical Activity Questionnaire From enrollment to study completion (2-3 months) Participant self-report. Scale is 1-7 indicating the number of days a type of physical activity was performed in the previous week. Items are different types of physical activity behaviors.
Care plan changes From enrollment to study completion (2-3 months) review of EHR data related to PCP visit, assess if any CKD-related information or changes were documented
Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences From enrollment to study completion (2-3 months) Participant self-report. Items and response options vary and ask questions about social determinants of health issues (e.g., food insecurity, housing insecurity). Screening tool with no scores.